Technetium 99m Ethylcysteinate Dimer Single-Photon Emission Computed Tomography (SPECT) During Intellectual Stress Test in Children and Adolescents With Pure Versus Comorbid Attention-Deficit Hyperactivity Disorder (ADHD)

Abstract

Children and adolescents with the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) diagnosis of attention-deficit hyperactivity disorder (ADHD) can have comorbid conditions such as conduct disorder, oppositional defiant disorder, and obsessive-compulsive disorder (comorbid type). The purpose of our study was to compare the pattern of regional cerebral perfusion in these two groups of children with ADHD during a computerized performance test. Nineteen children and adolescents were enrolled in the study. Seven boys and one girl with pure ADHD (group 1: mean age 12 years, range 9—16 years) and nine boys and two girls with comorbid ADHD (group 2: mean age 11 years, range 8—16 years) were studied by single-photon emission computed tomography (SPECT). The patients were not receiving any medication for at least 48 hours prior to the study. All patients were injected with ^99mTc- ethylcysteinate dimer while doing a computerized performance test. Nine age-matched control children (five boys and four girls, mean age 12 years, range 9—17 years) with a normal brain SPECT served as controls. All patients in group 2 showed significantly decreased perfusion in the temporal lobes (P < .005). Five patients had decreased frontal lobe perfusion. Additionally, two patients in group 2 had decreased perfusion in the basal ganglia (not significant). Four of eight patients in group 1 had decreased frontal lobe perfusion (not significant). In addition, two patients had bilateral temporal lobe abnormalities, whereas two patients had a normal SPECT. Three patients in group 1 also had decreased basal ganglia perfusion. In contrast to previous studies of brain perfusion in ADHD that focused mainly on frontal and prefrontal cortical abnormalities, our study demonstrates that temporal lobe perfusion abnormalities are more common in patients with the comorbid type of ADHD. We postulate that these findings can have therapeutic implications and explain the decreased response to stimulants in this group of patients. (J Child Neurol 2004; 19: 91—96).

Get full access to this article

View all access options for this article.

References

Brown RT , Freeman WS , Perrin JM , et al: Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 2001;107:E43.

Wolraich ML , Hannah JN , Baumgaertel A. , Feurer ID : Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 1998;19:162—168.

Rhee SH , Waldman ID , Hay DA , Levy F. : Sex differences in genetic and environmental influences on DSM-III-R attention-deficit/hyperactivity disorder. J Abnorm Psychol 1999;108:24—41.

Newcorn JH , Halperin JM , Jensen PS , et al: Symptom profiles in children with ADHD: Effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry 2001;40:137—146.

Geller DA , Biederman J. , Faraone SV , et al: Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: Fact or artifact? J Am Acad Child Adolesc Psychiatry 2002;41:52—58.

Seidman LJ , Biederman J. , Monuteaux Mc , et al: Learning disabilities and executive dysfunction in boys with attention-deficit/hyperactivity disorder. Neuropsychology 2001;15:544—556.

Wolraich ML , Lindgren S. , Stromquist A. , et al: Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 1990;86:95—101.

Levy F. , Barr C. , Sunohara G. : Directions of aetiologic research on attention deficit hyperactivity disorder . Aust N Z J Psychiatry 1998;32:97—103.

Pincus JH , Glaser GH : The syndrome of “minimal brain damage ” in childhood . N Engl J Med 1966;275:27—35.

10.

Sagvolden T. , Sergeant JA : Attention deficit/hyperactivity disorder— From brain dysfunctions to behaviour. Behav Brain Res 1998; 94:1—10.

11.

Castellanos FX , Giedd JN , Marsh WL , et al: Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder . Arch Gen Psychiatry 1996;53:607—616.

12.

Mann CA , Lubar JF , Zimmerman AW , et al: Quantitative analysis of EEG in boys with attention-deficit-hyperactivity disorder: Controlled study with clinical implications. Pediatr Neurol 1992;8:30—36.

13.

Zametkin AJ , Liebenauer LL , Fitzgerald GA , et al: Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993;50:333—340.

14.

Benson DF : The role of frontal dysfunction in attention deficit hyperactivity disorder . J Child Neurol 1991;6 (Suppl 6):S9—S12.

15.

Forbes GB : Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder. J Clin Psychol 1998;54:461—476.

16.

Greenberg LM , Waldman ID : Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry 1993;34:1019—1030.

17.

Catafau AM , Lomena FJ , Pavia J. , et al: Regional cerebral blood flow pattern in normal young and aged volunteers: A 99mTc-HMPAO SPET study. Eur J Nucl Med 1996;23:1329—1337.

18.

Filipek P. , Semrud Clikeman M , Steingard RJ , et al: Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997;48:589—601.

19.

Baumgardner TL , Singer HS , Denckla MB , et al: Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology 1996;47:477—482.

20.

O'Tuama La , Treves ST : Brain single-photon emission computed tomography for behavior disorders in children. Semin Nucl Med 1993;23:255—264.

21.

Lou HC , Henriksen L. , Bruhn P. : Focal cerebral dysfunction in developmental learning disabilities . Lancet 1990;335:8—11.

22.

Sieg KG , Gaffney GR , Preston DF , Hellings JA : SPECT brain imaging abnormalities in attention deficit hyperactivity disorder . Clin Nucl Med 1995;20:55—60.

23.

Lou HC , Henriksen L. , Bruhn P. : Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 1984;41:825—829.

24.

Zametkin AJ , Nordahl TE , Gross M. , et al: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323:1361—1366.

25.

Ernst M. , Liebenauer LL , King AC , et al: Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994;33:858—868.

26.

Matochik JA , Liebenauer LL , King AC , et al: Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment . Am J Psychiatry 1994 ; 151:658—664.

27.

Niedermeyer E. : Frontal lobe functions and dysfunctions . Clin Electroencephalogr 1998;29:79—90.

28.

Blumer D. , Heilbronn M. , Himmelhoch J. : Indications for carbamazepine in mental illness: Atypical psychiatric disorder or temporal lobe syndrome? Compr Psychiatry 1988;29:108—122.

29.

Devinsky O. , Bear D. : Varieties of aggressive behavior in temporal lobe epilepsy. Am J Psychiatry 1984;141: 651—656.

30.

Amen DG , Carmichael BD High-resolution brain SPECT imaging in ADHD. Ann Clin Psychiatry 1997;9:81—86.

31.

Pliszka SR , Liotti M. , Woldorff MG : Inhibitory control in children with attention-deficit/hyperactivity disorder: Event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 2000;48:238—246.

32.

Rubia K. , Overmeyer S. , Taylor E. , et al: Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. Am J Psychiatry 1999;156:891—896.

33.

Oades RD : Frontal, temporal and lateralized brain function in children with attention-deficit hyperactivity disorder: A psychophysiological and neuropsychological viewpoint on development. Behav Brain Res 1998;94:83—95.

34.

Shue KL , Douglas VI : Attention deficit hyperactivity disorder and the frontal lobe syndrome . Brain Cogn 1992;20:104—124.

35.

Volavka J. , Martell D. , Convit A. : Psychobiology of the violent offender. J Forens Sci 1992;37:237—251.

36.

Johnston C. , Pelham WE , Hoza J. , Sturges J. : Psychostimulant rebound in attention deficit disordered boys. J Am Acad Child Adolesc Psychiatry 1988;27:806—810.

37.

Nasrallah HA , Loney J. , Olson SC , et al: Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry Res 1986;17:241—246.

38.

Xiberas X. , Martinot JL , Mallet L. , et al: Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br J Psychiatry 2001;179:503—508.

39.

Schreier HA : Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol 1998;8:49—59.

40.

Kewley GD : Risperidone in comorbid ADHD and ODD/CD. J Am Acad Child Adolesc Psychiatry 1999;38:1327—1328.